40 results on '"Ogata, T"'
Search Results
2. 1393P Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy
3. 1418P Chronological improvement in the survival of advanced gastric cancer patients in the past 15 years
4. P-155 A phase I study of FLOT as first-line therapy for Japanese patients with advanced gastric cancer including patients with or without severe peritoneal metastasis
5. P-28 Exploratory analysis of patients with gastric/GEJ adenocarcinoma with or without liver metastasis from the phase 3 RAINBOW study
6. 615P The impacts of starting regorafenib dose on treatment outcomes in metastatic colorectal cancer
7. 1562P Claudin 18.2 expression in resected gastric cancer
8. P-253 Multimodal analgesia combined with epidural anesthesia and intravenous administration of acetaminophen in perioperative management of esophagectomy using modified ERAS protocol
9. P-199 Comparison of treatment outcomes of regorafenib for patients with metastatic colorectal cancer by era: A propensity-score matched analysis
10. 135P Significance of lymphatic invasion in the indication for additional gastrectomy after endoscopic treatment
11. 1439P Phase II study to evaluate feasibility and safety of oral nutritional supplementation with high density liquid diet after total gastrectomy for patients with gastric cancer
12. P-163 Systemic chemotherapy for previously treated metastatic small bowel adenocarcinoma
13. P-158 Clinical impact of oral intake in third-line treatment for advanced gastric cancer
14. Neoadjuvant chemotherapy can eliminate the negative impact of postoperative infectious complications on recurrence in patients with esophageal cancer
15. Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study
16. The safety and efficacy of FOLFOXIRI plus molecular target therapy as a first-line treatment for metastatic colorectal cancer: A multicentre retrospective study
17. The difference of risk factor for gastric cancer surgery between elderly and non-elderly patients
18. Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?
19. Can preoperative diagnosis select therapeutic target of neoadjuvant chemotherapy for gastric cancer?
20. Trifluridine/tipiracil vs regorafenib as salvage-line treatment in patients with metastatic colorectal cancer: A multicenter retrospective study
21. Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: A retrospective study
22. Feasibility study of preoperative chemotherapy for esophageal cancer with naso-gastric ED tube for patients with difficulty of oral ingestion
23. Optimal cutoff of histological response by neoadjuvant chemotherapy for gastric cancer
24. Priority of lymphadenectomy for each station in elderly patients with middle to distal advanced gastric cancer
25. Impact of preoperative sarcopenia on overall survival in gastric cancer surgery
26. 766P - Neoadjuvant chemotherapy can eliminate the negative impact of postoperative infectious complications on recurrence in patients with esophageal cancer
27. Serum phosphorylated neurofilament heavy subunit as a predictive marker of chemotherapy-induced cognitive impairment: a preliminary result
28. Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial
29. 692P - The difference of risk factor for gastric cancer surgery between elderly and non-elderly patients
30. 657P - Can preoperative diagnosis select therapeutic target of neoadjuvant chemotherapy for gastric cancer?
31. 639P - Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?
32. 480P - The safety and efficacy of FOLFOXIRI plus molecular target therapy as a first-line treatment for metastatic colorectal cancer: A multicentre retrospective study
33. P-233 - Trifluridine/tipiracil vs regorafenib as salvage-line treatment in patients with metastatic colorectal cancer: A multicenter retrospective study
34. P-067 - Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: A retrospective study
35. 225P - Feasibility study of preoperative chemotherapy for esophageal cancer with naso-gastric ED tube for patients with difficulty of oral ingestion
36. 214P - Priority of lymphadenectomy for each station in elderly patients with middle to distal advanced gastric cancer
37. 215P - Optimal cutoff of histological response by neoadjuvant chemotherapy for gastric cancer
38. 211P - Impact of preoperative sarcopenia on overall survival in gastric cancer surgery
39. 398P Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): Additional analysies from 45-month (mo) follow-up of CheckMate 648.
40. P-165 - Safety and effectiveness of direct oral anticoagulants for venous thromboembolism in patients with active cancer: a retrospective study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.